The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through ...
Epion Therapeutics announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to ...
The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...